These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16915040)

  • 1. Telmisartan inhibits beta2-integrin MAC-1 expression in human T-lymphocytes.
    Link A; Lenz M; Legner D; Böhm M; Nickenig G
    J Hypertens; 2006 Sep; 24(9):1891-8. PubMed ID: 16915040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telmisartan suppresses cerebral injury in a murine model of transient focal ischemia.
    Kasahara Y; Taguchi A; Uno H; Nakano A; Nakagomi T; Hirose H; Stern DM; Matsuyama T
    Brain Res; 2010 Jun; 1340():70-80. PubMed ID: 20388500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the angiotensin II type 1 receptor antagonist telmisartan on monocyte adhesion and activation in patients with essential hypertension.
    Syrbe U; Moebes A; Scholze J; Swidsinski A; Dörffel Y
    Hypertens Res; 2007 Jun; 30(6):521-8. PubMed ID: 17664855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of angiotensin II type 1 receptor in the regulation of cellular adhesion molecules in atherosclerosis.
    Prasad A; Koh KK; Schenke WH; Mincemoyer R; Csako G; Fleischer TA; Brown M; Selvaggi TA; Quyyumi AA
    Am Heart J; 2001 Aug; 142(2):248-53. PubMed ID: 11479463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
    Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
    Clin Ther; 2009 Oct; 31(10):2113-25. PubMed ID: 19922882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan.
    Okunuki Y; Usui Y; Nagai N; Kezuka T; Ishida S; Takeuchi M; Goto H
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2255-61. PubMed ID: 19136706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization.
    Nagai N; Oike Y; Izumi-Nagai K; Urano T; Kubota Y; Noda K; Ozawa Y; Inoue M; Tsubota K; Suda T; Ishida S
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2252-9. PubMed ID: 16888236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II receptor antagonism with telmisartan increases number of endothelial progenitor cells in normotensive patients with coronary artery disease: a randomized, double-blind, placebo-controlled study.
    Pelliccia F; Pasceri V; Cianfrocca C; Vitale C; Speciale G; Gaudio C; Rosano GM; Mercuro G
    Atherosclerosis; 2010 Jun; 210(2):510-5. PubMed ID: 20044087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonist.
    Maillard MP; Perregaux C; Centeno C; Stangier J; Wienen W; Brunner HR; Burnier M
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1089-95. PubMed ID: 12183667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels.
    Takahashi Y; Satoh M; Minami Y; Tabuchi T; Itoh T; Nakamura M
    Clin Sci (Lond); 2010 Jul; 119(9):395-405. PubMed ID: 20524934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan improves insulin resistance in high renin nonmodulating salt-sensitive hypertensives.
    Sanchez RA; Masnatta LD; Pesiney C; Fischer P; Ramirez AJ
    J Hypertens; 2008 Dec; 26(12):2393-8. PubMed ID: 19008718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice.
    Blessing E; Preusch M; Kranzhöfer R; Kinscherf R; Marx N; Rosenfeld ME; Isermann B; Weber CM; Kreuzer J; Gräfe J; Katus HA; Bea F
    Atherosclerosis; 2008 Aug; 199(2):295-303. PubMed ID: 18093593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.
    Imayama I; Ichiki T; Inanaga K; Ohtsubo H; Fukuyama K; Ono H; Hashiguchi Y; Sunagawa K
    Cardiovasc Res; 2006 Oct; 72(1):184-90. PubMed ID: 16938288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3-L1 adipocytes.
    Fujimoto M; Masuzaki H; Tanaka T; Yasue S; Tomita T; Okazawa K; Fujikura J; Chusho H; Ebihara K; Hayashi T; Hosoda K; Nakao K
    FEBS Lett; 2004 Oct; 576(3):492-7. PubMed ID: 15498586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation.
    Fliser D; Buchholz K; Haller H;
    Circulation; 2004 Aug; 110(9):1103-7. PubMed ID: 15313950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin elevation by telmisartan ameliorates ischaemic myocardium in Zucker diabetic fatty rats with metabolic syndrome.
    Rinaldi B; Di Filippo C; Capuano A; Donniacuo M; Sodano L; Ferraraccio F; Rossi F; D'Amico M
    Diabetes Obes Metab; 2012 Apr; 14(4):320-8. PubMed ID: 22050607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute regulation of pancreatic islet microcirculation and glycaemia by telmisartan and ramipril: discordant effects between normal and type 2 diabetic rats.
    Olverling A; Huang Z; Nyström T; Sjöholm Å
    Clin Sci (Lond); 2013 Nov; 125(9):433-8. PubMed ID: 23713675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension.
    Benndorf RA; Rudolph T; Appel D; Schwedhelm E; Maas R; Schulze F; Silberhorn E; Böger RH
    Metabolism; 2006 Sep; 55(9):1159-64. PubMed ID: 16919533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing renal complications in type 2 diabetes: results of the diabetics exposed to telmisartan and enalapril trial.
    Barnett A
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S132-5. PubMed ID: 16565237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor.
    Nagai N; Oike Y; Noda K; Urano T; Kubota Y; Ozawa Y; Shinoda H; Koto T; Shinoda K; Inoue M; Tsubota K; Yamashiro K; Suda T; Ishida S
    Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2925-31. PubMed ID: 16043867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.